GulfBase Live Support
24/12/2017 06:18 AST
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a rights issue. The company has received approval from the Capital Market Authority (CMA) for the rights issue and accordingly, 50 million shares will be issued to the existing shareholders at a price of 102 baisas per share.
The board of directors of the company approved a proposal to raise of the company's capital from OMR5 million to OMR10 million.
The CMA approved the rights issue prospectus based on the request of the company's management and in compliance with all the requirements of the issue.
Times of Oman
| Ticker | Price | Volume |
|---|
22/12/2025
Visa and Aldar have announced a strategic collaboration that marks the first live implementation of Visa Intelligent Commerce in the region, introducing end-to-end, voice-enabled agentic payment expe
Khaleej Times
22/12/2025
The National Bank of Bahrain (NBB) has signed a strategic agreement with Procural, a Bahrain-based digital procurement and tendering platform.
The collaboration supports NBB's ongoing digita
Trade Arabia
22/12/2025
Bahrain Ship Repairing & Engineering Company (BASREC) has signed a strategic agreement with Lumofy, an AI-powered talent development and competency management platform, as part of its commitment to a
Trade Arabia
22/12/2025
Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has announced that its Board of Directors has approved the appointment of Dr Shamsheer Vayalil as Chief Executive Off
Trade Arabia
22/12/2025
Aluminium Bahrain (Alba), the world's largest aluminium smelter on one site, has swiftly contained an industrial fire that broke out at a power rectiformer in the morning of December 19, a company st
Trade Arabia